GSK : announces positive results from phase III severe asthma trials of depemokimab - Form 6-K
A1901p UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
Source: marketscreener.com
Stay updated with breaking news from Steph Mountifield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A1901p UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
A8223o UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER...
Investegate announcements from GSK announces intention to sell shares in Haleon
DURHAM, N.C.--(BUSINESS WIRE)--Apr 8, 2024--
Investegate announcements from EMA accepts Arexvy filing for adults 50-59 at risk